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ABSTRACT 
 
Objectives Making the diagnosis of asthma is challenging. Guidelines recommend that 
clinicians identify a group at ‘high probability’ of asthma. ‘High probability’, however, is not 
numerically defined giving rise to uncertainty. The aim of this work was to build consensus on 
what constitutes a ‘high probability’ of asthma in primary care. ‘High probability’ was defined as 
the probability threshold at which there is enough information to make a firm diagnosis of 
asthma and a subsequent negative test would not alter that opinion (assumed to be a false 
negative). 
 
Design Mixed methods study 
 
Setting A consensus workshop using modified Nominal Group Technique was held during 
an international respiratory conference. 
 
Participants International conference attendees eligible if they had knowledge/experience 
of working in primary care, respiratory medicine and spoke English. 
 
Methods Participants took part in facilitated discussions and voted over three rounds on 
what constituted a high probability of asthma diagnosis. The workshop was audio-
recorded, transcribed and qualitatively analysed. 
 
Results Based on final votes, the mean value for a high probability of asthma in primary care was 
75% (SD 7.6), representing a perceived trade-off between limiting the number of false positives 
(more likely if a lower threshold was used) and pragmatism on the basis that first-line preventive 
therapies (i.e. low-dose inhaled corticosteroids) are relatively low risk.  The need to review 
response to treatment was strongly emphasised for detecting non-responders and reviewing the 
diagnosis.    
 
Conclusion A consensus probability of 75% was the threshold at which the primary care 
participants in this workshop felt confident to establish the diagnosis of asthma, albeit with the 
caveat that a review of treatment response was essential. Contextual factors including availability 
and timing of tests and the ease with which patients could be reviewed influenced participants 
decision making. 
 
Word count 289/300 
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Strengths and limitations of this study 
 This study achieved consensus on a value for ‘high probability’ of asthma diagnosis in 
primary care. 
 Qualitative analysis provided insight into the contextual factors that affect the decision 
making of health professionals when assessing someone with symptoms to suggest 
asthma 
 We recruited 10 participants, the suggested number for a modified Nominal Group 
Technique workshop, yet because of the small sample, the statistical analysis should 
be interpreted cautiously and in conjunction with the qualitative analysis. 
 Participants were recruited from an international conference and, reflecting the majority 
of delegates, were doctors working in primary care from around the world with interest 
in respiratory medicine.  
 We chose not to include clinicians from secondary/tertiary care because health 
problems typically present differently between primary and secondary care settings. 
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BACKGROUND 
Mis-diagnosis of asthma is common with both under-diagnosis and over-diagnosis 
reported.[1–3] Asthma is difficult to diagnose because it is a heterogeneous disease with 
different underlying disease processes, defined by variable symptoms and expiratory 
airflow limitation.[4] Investigations can determine key features of asthma, but all have 
limitations. For instance, spirometry is considered the reference standard for diagnosing 
airway obstruction,[5] but airway obstruction may not be persistent, or present in all cases 
of asthma.[6] Bronchial provocation is the reference standard for determining bronchial 
hyper-responsiveness[7] but is time consuming, carries a risk of inducing severe 
bronchospasm[8] and is not widely available internationally. Fractional exhaled Nitric Oxide 
(FeNO) identifies airway inflammation and is useful for ruling-in, but less helpful for ruling-
out asthma.[9] Peak flow variability is straightforward to perform but has low diagnostic 
accuracy for asthma.[10,11] In the absence of an investigation that can rule-in or rule-out 
asthma with high certainty, the diagnosis of asthma is often made clinically. 
 
Therefore, if asthma is suspected in people presenting with undifferentiated symptoms 
(typically to primary care), health professionals are recommended to build up evidence for 
or against the presence of the diagnosis by undertaking a structured clinical 
assessment.[4,12,13] Current guidelines differ in their recommendations about the steps 
needed to achieve an asthma diagnosis.[4,12,13] The Global Initiative for Asthma (GINA) 
and the National Institute for Health and Care Excellence (NICE) advise that anyone 
suspected of asthma should be assessed with spirometry, peak flow variability and/or 
FeNO.[4,13] If uncertainty remains after initial investigations, repeating tests after an 
interval, or additional testing (such as bronchial provocation) are advised.[4,13]  The British 
Thoracic Society (BTS)/Scottish Intercollegiate Guideline Network (SIGN) advise weighing 
up the probability that an individual has asthma.[12] In the case of intermediate or low 
probability further investigations are necessary.[12] Individuals judged to be at high 
probability of asthma may be coded as having suspected asthma, and a monitored trial of 
treatment initiated with clear plans for re-assessment.[12]  
 
The differences between asthma guidelines has unfortunately led to confusion amongst 
some health professionals.[14] Furthermore, as asthma is a variable, heterogeneous 
condition, the clinical picture is not always obvious, and in some instances, diagnostic 
investigations, which may deliver false positive or false negative results, can add to 
uncertainty.   
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The probability of asthma is informed by all available information which will include a clinical 
assessment, previous clinical records as well as the results of any investigations that have 
been undertaken. Choosing if and when to conduct a further investigation or to commence 
treatment is conceptualised in the thresholds approach to diagnosis.[15] The ‘test-
treatment’ threshold indicates the point at which further testing would be unlikely to alter 
the probability of the diagnosis. If an individual is below the test-treatment threshold, then 
further information or investigations are likely to help decision making and should be 
completed.[15] If the probability is higher than the test-treatment threshold, further 
investigations are unlikely to improve the probability, so the diagnosis can be confirmed, 
and treatment started.[15] In the context of asthma, probability above the test-treatment 
threshold would lead to a ‘suspected asthma’ code and a monitored trial of treatment.[12]  
 
Having a numerically defined threshold could bring clarity over what guidelines describe as 
‘high probability’ of asthma,[12] which would also facilitate greater consistency between 
clinicians regardless of their levels of experience. Secondly, in the context of clinical 
prediction models for asthma diagnosis,[16] it may be possible to input clinical assessment 
and investigation results into an algorithm and generate a numerical probability that asthma 
is present. A consensus on the test-treatment threshold could help clinicians to make sense 
of the output of such algorithms.  
 
Therefore, this study sought to achieve consensus for the test-treatment threshold for 
asthma diagnosis in adults; identifying the probability at which primary care clinicians can 
feel confident they have enough information to make a diagnosis, and information from 
additional investigations is unlikely to change their diagnosis.  
 
METHODS 
We undertook a consensus workshop using modified Nominal Group Technique (NGT) 
methodology.[17,18] The workshop was held during an International Primary Care 
Respiratory Group (IPCRG) conference, in Bucharest, Romania in May 2019. Workshop 
materials were developed by the research team and piloted during a practice event held 
with colleagues from the Asthma UK Centre for Applied Research, six weeks in advance. 
The study protocol was reviewed and approved by the University of Edinburgh sponsor 
(Number: AC19047) who recommended no further ethical review was required. 
 
Recruitment 
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Potential participants were identified from the publicly available IPCRG conference 
programme with support from the conference organisers. Participants were eligible if they 
had knowledge and experience of working in primary care or equivalent settings and had 
sufficient fluency in English to take part in the discussion. We sought 10 participants (the 
suggested number for a modified NGT consensus)[17] from clinical backgrounds with a 
specialist interest in asthma, and from a range of countries. Potential participants were 
contacted by email with an information sheet. 
 
Data collection 
A first round of voting was conducted by email two weeks before the face-to-face 
workshop. Participants were asked: “At what probability would you consider someone to 
be at high probability of asthma diagnosis?” and provided an answer (an integer between 
0 and 100%) anonymously.  
 
At the beginning of the face-to-face workshop, participants were provided with a detailed 
explanation of the session and asked to sign a consent form. Participants received a 20-
minute presentation with definitions of key terms, an explanation of the rationale and 
anonymised feedback from the first round of voting (Table 1). Remaining uncertainties 
were addressed before participants voted for a second time (anonymously) on the 
question; “At what probability would you consider someone to be at high probability of 
asthma diagnosis?” 
 
Content Description 
Challenges relating 
to asthma diagnosis  
Presentation of the definition of asthma, rates and consequences of 
misdiagnosis and the lack of a ‘gold’ standard test for asthma. 
Approaches to 
asthma diagnosis  
Recommendations from the Global Initiative for Asthma[4]  and 
National Institute for Health and Care Excellence[13] presented 
Threshold approach 
to diagnosis[15] 
The threshold approach to diagnosis was explained with asthma 
specific cases and diagrams. 
Probability of an 
asthma diagnosis 
Two cases were presented demonstrating how the probability of a 
diagnosis can vary depending on the information available at 
different times and before and after investigation(s).  
Table 1. Outline of the information provided to participants before round 2 voting 
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Anonymised results of the second round of voting were displayed graphically and 
reviewed by the group. Participants discussed the question and considered the pros and 
cons of choosing too high, or too low a value for the threshold. Discussion was facilitated 
by two researchers, both academic GPs with materials including two clinical cases used 
to direct the conversation. A final round of anonymous voting on the research question 
was completed, marking the end of the workshop.  
 
Data analysis 
Each round of participant voting was visualised graphically and analysed using descriptive 
statistics (mean, standard deviation and range) using R.  The workshop was, with permission 
of participants, audio-recorded and transcribed. The workshop discussion was analysed 
qualitatively using a thematic approach.[19] The transcript was read, and initial coding 
completed using NVivo 10 (QSR international). Codes were collected into potential themes, 
and a final coding framework agreed upon following discussion within the research team.  
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RESULTS 
26 people were approached (selected to try and achieve a broad range of nationalities), of 
whom 10 participants (four female) from nine countries were available and recruited into the 
study. Table 2 lists the countries of origin and professional backgrounds of the participants. 
Though not formally assessed, each participant was sufficiently fluent in English to take an 
active role in the discussion. All participants had a specialist interest in respiratory healthcare. 
A complete set of votes were received for every round except for one participant in Round 1. 
Based on the final round of voting, the mean consensus value for the threshold constituting 
high probability of asthma was 75% (SD 7.6). By the final round of voting, there was less 
variation between participants compared to round 1 and 2, with the lowest and highest votes 
65% and 85%, respectively (Table 3).   
Region Countries Professional role 
Northern Europe Germany, Netherlands, Sweden, UK   
4 Academic GPs 
1 GP with multiple roles 
Southern Europe Portugal, Spain 2 Academic GPs 
Eastern Europe Romania 1 Asthma/allergy physician 
Far East subcontinent Malaysia 1 Academic GP 
Australasia Australia 1 Academic GP 
Table 2. Countries of origin and professional background of the participants 
 
Participant Round 1 Round 2 Round 3 
A 80% 75% 70% 
B 95% 95% 65% 
C 80% 70% 65% 
D 70% 90% 80% 
E 80% 80% 65% 
F 80% 70% 80% 
G 80% 85% 85% 
H 100% 80% 80% 
I - 90% 80% 
J 80% 65% 75% 
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Mean (SD) 83% (9.1) 80% (10.0) 75% (7.6) 
Table 3. Participant votes across the three rounds 
 
Figure 1 displays how voting frequencies changed between rounds. The first round, 
completed via email, showed a peak of votes at 80%, with few participants choosing a 
‘high’ threshold (for example 95 or 100%). Round 2, completed after a 20-minute 
introduction and explanation demonstrated more variation amongst participants, with no 
clear majority. The final voting round, after the facilitated discussion, showed a general 
reduction in the threshold voted for and two values, 65% and 80%, attracting several 
votes.  
Influences on participant decision making 
Reviewing the discussion identified a number of factors that shaped the evolution of 
participants decision making on what the threshold should be. The context in which each 
participant worked, and the resources available to them influenced their choice of 
threshold. Some participants had ready access to investigations, which enabled them to 
complete testing quickly and easily.  
“I have a spirometer in my office and […] I love to depict the patients at once” 
Participant F 
Another participant explained that the timing at which spirometry was performed could make 
a difference to the interpretation:  
“We can get a full spirometry in a week where I work. But if we would have 
to wait for 2 weeks then they [the patient] would probably be better by then. 
So, it depends on when they get the test.” Participant H   
In contrast, Participant B shared how she dealt with a suspected asthma patient in a low 
resource setting:  
“We don’t have access to spirometry, and we have very limited peak flow at 
the clinics, so if I have a patient at the clinic presenting with wheezing and 
some degree of asthma history, the aim is to provide a treatment so that 
they can go home better rather than really getting the diagnosis” Participant 
B 
‘Asthma’ as a diagnostic label? 
 10
Regardless of the health system or availability of investigations, some participants argued that 
providing treatment may be an appropriate option even without a precise diagnostic label:  
 “Well it’s all about the ‘game’ you are in…and the ‘game’ we are in is 
reducing the number of symptoms and reducing the risk, that’s the ‘game’ 
we are in. We are not in the ‘game’ of this is asthma or this is not asthma” 
Participant J 
“…it’s our job as a GP to decide if someone is ill or not together with the 
summarisation of different test(s), so if someone has a really clear history 
[of asthma] but spirometry doesn’t help me in that patient at that moment, 
then I treat him despite a negative spirometry” Participant F 
In addition, Participant C explained that using ‘asthma’ as a diagnostic label was a problem 
as contemporary understanding of asthma is not as a single disease:   
“...asthma is not a disease, there is not one asthma, there is different 
‘asthmas’…So that is the main problem, we are diagnosing with one word 
many diseases, different pathophysiologies, different things” Participant C 
Different ‘tests’ for asthma 
In the absence of a ‘gold standard’ investigation for asthma, and understanding asthma 
to be a heterogeneous disease, participants discussed strategies they used to make a 
diagnosis of asthma: 
“We get information from several diagnostic tests. So, the medical history is 
a diagnostic test, physical examination is a diagnostic test, spirometry, peak 
flow variability and so on. And we as physicians sometimes decide which 
test we accept, or refuse, and we make a mixture in our minds somehow 
and come to the final diagnosis.” Participant F 
Response to treatment was also considered to be an important tool in weighing up the 
evolving likelihood of asthma: 
“I use that trial [of treatment] as one of my tests. I have a different probability 
depending on their response to that trial than I would making that decision. 
So, my threshold for instituting the trial of treatment might be 50 or 60% but 
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my probability where no test is going to change my mind, after that trial 
would be quite different” Participant I 
Consequences of a low threshold for diagnosing asthma 
Discussing the likely clinical course when making a diagnosis of asthma helped some 
participants to consider the acceptability of diagnosing asthma at a lower probability: 
“I’m not going to operate on them, I’m not going to give them radiotherapy 
or chemotherapy, I’m going to give them a bit of inhaled corticosteroid for 
six weeks…my level of probability has actually come down a bit as I’ve 
begun to think about it because I’m not so worried about the consequence 
of having a lower threshold because it’s not so bad having six weeks of 
inhaled corticosteroid.” Participant A 
If a lower threshold for diagnosing asthma was used, more people would be labelled as having 
asthma and if started on first-line treatment (low-dose inhaled corticosteroids) the risk of 
asthma attack would potentially be lower. Participant I highlighted how an episode of 
thunderstorm asthma demonstrated the potential for severe and fatal asthma attack even in 
those not aware of having the disease: 
“we had 11 people die, [and] a whole heap hadn’t had or didn’t think they 
had asthma, and these were the ones that ended up in the emergency 
department” Participant I 
The advantages of a high threshold for diagnosing asthma  
Whilst there could be advantages for a lower threshold for diagnosing asthma, a 
consequence would be an increase in the number of patients wrongly labelled with 
asthma (false positives). Though the initial treatment of asthma may be considered 
relatively safe, providing ongoing treatment for the wrong diagnosis would have 
implications: 
“A person who hasn’t got asthma, who is being treated for asthma with 
escalating doses of anti-inflammatory medication, either high dose inhaled 
corticosteroids or oral corticosteroids are being subject to a medication that 
isn’t going to help them, but they are also not getting treatment for the 
disease that they have got. So, it’s a double whammy.” Participant G 
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If a person was wrongly labelled with asthma, the consequences would also depend on the 
missed diagnosis that was the cause for the symptoms:  
“There are no consequences of actually having the wrong diagnosis, if the 
alternative is that she doesn’t have any other diagnosis. But if the alternative 
is that she has a lung embolus she’s dead next day.” Participant J 
The safety net of follow up 
As well as considering consequences, participants discussed how confident they would be 
that a person who had been mis-diagnosed would be identified and subsequently correctly 
diagnosed. In the case of someone starting treatment for asthma, Participant D explained that 
in her context once a person had been started on a treatment there would be an opportunity 
to review the treatment, and ultimately check that the diagnosis was correct:  
“The GP is obliged to send to a specialist to confirm the diagnosis, to review 
the treatment. I think that is a good thing because the patient comes to me 
‘just give me another letter to continue the treatment’ and I say no, we have 
to review the diagnosis with spirometry at the clinic and step [treatment] up 
or down.” Participant D 
Participant E agreed that it “might be very nice confirming all your [asthma] diagnoses” but felt 
it was “unthinkable” in their country because it would [flood the hospitals], therefore review 
was organised within primary care. For Participant B, reviewing patients was harder as they 
explained often “[people] won’t come back”.    
In the situation where a person did have asthma, but it had not been identified, Participant E 
felt that, “[the diagnosis] can only be recognised and corrected if the patient comes back 
with symptoms”. 
Sharing the uncertainty  
Participant A, elaborated further by explaining that if asthma had been considered but 
decided against, discussing this uncertainty with a patient felt like “an easy conversation 
to have”: 
“I guess most health professionals have a conversation saying ‘I don’t 
think this is asthma, if I don’t treat you, you may carry on having symptoms 
for a while but if you don’t then it means it wasn’t that…‘I won’t treat you [just 
yet] because I want to see whether or not you get better on your own’ 
Participant A 
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Dealing with uncertainty and screening for red flags were felt to be common features of general 
practice:  
“We have to be able to deal with uncertainty, but also to know very well your 
red flags... TB, pulmonary embolism and so on. Those are the red flags that 
we need to have all the time when we think this patient might have asthma 
but might have something else. And that something else needs to be ruled 
out for sure and yet still you have to live with uncertainty. That’s the rule in 
general practice.” Participant E 
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DISCUSSION 
Principal findings 
The consensus threshold at which the diagnosis of asthma in primary care was considered 
high probability was 75%. This figure is the mean value of the threshold score of 10 
international primary care-based respiratory interested participants and indicates the level at 
which participants were comfortable to code an individual with suspected asthma and start a 
monitored trial of treatment.  Taken together with the qualitative data, the value may suggest 
a compromise between limiting the number of false positives that would be generated by using 
too low a threshold, and on the other hand, being pragmatic and understanding that as a first-
line treatment, low-dose inhaled corticosteroid does not carry high risks if a review can be 
ensured at which the response to treatment can be assessed and treatment dosages adjusted. 
Strengths and weaknesses 
We opted to use modified NGT methodology as we felt a detailed discussion would be best 
achieved through face-to-face discussion.[17,18] Subsequently, we recruited 10 participants, 
the suggested number for a modified NGT.[17] We acknowledge that with a small sample, our 
statistical analysis should be interpreted with caution as it is possible that had the participants 
been different or discussed the topic on another occasion the voting may have been different. 
Using a mixed methods approach helped to balance our interpretation.  
We recruited from IPCRG conference attendees and our sample reflected the majority of 
conference delegates; doctors working in primary care from around the world with experience 
and interest in respiratory medicine. As a purposive sample, we achieved views from a range 
of nations, but the findings may not be applicable to all countries.  Despite our efforts we failed 
to recruit any nurses to this study. However, unlike in the UK where nurses have a central 
role, the diagnosis and management of asthma internationally is largely doctor-led. We would 
have achieved a broader perspective by including secondary/tertiary care clinicians, but we 
chose not to because the focus of the study was asthma diagnosis in primary care, and health 
problems such as respiratory symptoms typically present differently between primary and 
secondary care settings[20,21]     
Interpretation 
Pragmatic practice 
75% was the consensus value for the test-treatment threshold based on ten participants and 
its utility and safety needs to be further investigated before adoption into practice. In the final 
round of voting, there remained a spread of opinion; three participants voted for 65% and four 
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for 80%. Taken together with the qualitative analysis, we felt that there were two broad groups 
of opinion. For those opting for a lower threshold, there were a number of reasons that being 
able to make a diagnosis of asthma at lower probability made sense. Firstly, having a high 
probability of disease was less important than delivering the right treatment.  Understanding 
asthma to be an umbrella term (i.e. not a single disease) raised questions about the validity 
and value of using asthma as a diagnostic term.[22] Instead of asthma, ‘treatable traits’ offer 
a more personalised approach to classification and management,[23] and the priority is in 
delivering the right treatment to the individual. This practical approach to ‘making the patient 
better’ was shared by those in low-resource settings, who lacked investigations and had little 
confidence that a patient would return for a review. The pragmatic approach was to exclude 
serious differential diagnoses (such as TB, pulmonary embolus) and provide treatment for the 
most likely problem.  
Those who chose 80% as a threshold for ‘high probability’ sought greater confidence that what 
they were treating had a diagnostic label of asthma. Being able to access the right 
investigations at the right time was important and provided confidence that the right diagnosis 
could be achieved. Reducing unnecessary prescription of inhaled corticosteroids was also a 
priority, with concern that mis-diagnosis can lead to escalation of treatment to high dose 
therapies.  
Current guidelines 
Currently, there is no definitive evidence to recommend a best approach for diagnosing 
asthma in clinical settings and consequently, international guidelines make different 
recommendations.[4,12,13] The BTS/SIGN (2019) guideline recommends that those at high 
probability of asthma (defined as those having a clinical assessment ‘typical’ of asthma and 
no features to suggest an alternative diagnosis) should be recorded as ‘suspected asthma’ 
and begin a monitored trial of treatment.[12] The recommendation is pragmatic, recognising 
that in some instances, when the clinical picture is overwhelmingly in favour of asthma, 
reviewing after a trial of treatment may be the most appropriate course. However, the concept 
of ‘high probability’ may be interpreted differently amongst health professionals, and can lead 
to treatment being started inappropriately, rather than seeking to confirm the diagnosis with 
objective testing, principally spirometry with reversibility.[2]  
Asthma is a variable condition and demonstration of objective improvement with treatment 
(bronchodilators, inhaled steroids, oral steroids) may contribute to the diagnostic assessment. 
The concept of a ‘trial of treatment’ has been criticised as potentially leading to 
commencement of lifelong treatment without a clear diagnosis. Most participants in this study 
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took a different view, considering that commencing treatment as a formal ‘trial’ was the best 
way to prevent on-going inappropriate prescribing.  Indeed, it was the recognition that, as 
primary care clinicians they could ensure a review to assess response, titrate down (and 
potentially stop) treatment that contributed to a reduction in the test-treatment threshold for 
some participants. This echoes the structured approach to diagnosis illustrated in the 
BTS/SIGN guideline as a gap between a ‘trial of treatment’ in a patient ‘suspected’ of having 
asthma and commencing regular medication.[12] However, if a structured approach to 
diagnosis is not followed, and individuals suspected of having asthma are not re-assessed 
appropriately, poorly undertaken treatment trials may contribute to mis-diagnosis, with 
individuals treated inappropriately and unnecessary medication costs to the healthcare 
system. [24]    
In other guidelines, objective tests form a key part of the diagnostic work-up.[4,13] A lack of 
consistent objective testing (such as spirometry, peak flow and bronchial challenge testing) 
has been associated with a failure to confirm current asthma[2] leading to recommendations 
to shift from a perceived ‘no-test culture’ in asthma.[22] In this study of participants from 
different international healthcare settings, the ability to access and perform tests when they 
were needed varied. Some participants had spirometry in their office, but most had to wait for 
a period before spirometry could be completed, and one participant had no access to lung 
function testing. Accordingly, each participant had developed strategies for diagnostic 
investigation in the context in which they worked.   
Ensuring follow-up 
In this study, the final value for the test-treatment threshold (75%) was lower than the first two 
rounds of voting. Qualitative analysis of the discussion indicates that following the introductory 
presentation (before round 2), participants discussed the diagnostic process and were 
confident that, regardless of the probability threshold they chose, systems could be put in 
place to ensure patients were re-assessed. Whether to correct a false positive diagnosis and 
stop treatment, or to remedy a false negative diagnosis if symptoms developed, being able to 
review a patient was felt to be crucial in confirming (or changing) a diagnosis. Unfortunately, 
in practice, ensuring the review of individuals can be challenging, meaning that a diagnostic 
label or treatment response goes unreviewed. Using a ‘suspected asthma’ code is one way in 
which patients in whom the diagnosis has not been established may be identified, making it 
clear to health professionals in the future that the working diagnosis remains unverified.[12]    
Implications for policymakers, healthcare professionals and researchers 
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This study demonstrates that approaches for assessing asthma in primary care are strongly 
influenced by the clinical context in which they occur. However, there are general principles 
which policy makers should consider to help primary care clinicians improve the accuracy of 
an asthma diagnosis. Investigations for asthma, such as spirometry, should be accessible and 
achievable in a timely fashion. In low-resource settings, understanding how best to diagnose 
asthma with limited availability of investigations is important,[25] but with increasing 
technological solutions such as apps to allow lung function testing by mobile phone,[26] 
reliable methods to identify variable lung function should become more widespread. In high-
resource settings different healthcare models for achieving diagnostic tests exist, each with 
advantages and disadvantages. Respiratory testing within practices can be accessible for 
patients and potentially more straightforward to complete when a patient is symptomatic, 
however practices have concerns about the time taken,[27] and maintaining quality assurance 
can be resource intensive. Alternatives such as diagnostic referral centres [28] where a patient 
may attend for a wider range of tests in a single sitting, provide economies of scale, but might 
lead to a de-skilling of primary care practitioners.[14]    
Ensuring follow-up of patients during the diagnostic period will require varied solutions across 
different health systems. In low-resource settings, TB-specific programmes have shown 
improvements in follow-up after outpatient visits,[29] and plans to extend these initiatives to 
other diseases are being attempted as part of wider efforts to improve continuity of care, and 
patient-centred universal health coverage.[30] In high resource settings, such as the UK, 
policy makers and health professionals should consider how follow up may be affected as 
continuity in primary care becomes harder to achieve.[31]   
Findings from this study will inform the development of a clinical decision support system 
(CDSS) to aid the diagnostic decision making of asthma by primary care health professionals. 
In addition to providing a structured approach to diagnosis, a CDSS could also provide 
strategies to deal with diagnostic uncertainty. Shared decision making is often considered in 
the context of screening and treatment decisions.[32] Yet, uncertainty may be greater in 
diagnostic situations as, unlike treatment decisions where an existing condition has been 
categorised, diagnosis requires clarification of the cause of symptoms, making it more difficult 
to weigh up the options and decide on a management course.[32] CDSS and computer screen 
sharing during a consultation may offer practical solutions, for example, a structured approach 
guided by a CDSS embedded in the practice computer may change organisational pathways; 
sharing diagnostic uncertainty with the patient may help in communicating the importance of 
a review and improve the chances of follow-up.[33,34]  
CONCLUSION 
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A probability of 75% was the consensus threshold at which participants in this workshop felt 
confident to establish the diagnosis of asthma in primary care, albeit with the caveat that a 
review of treatment response was essential. Contextual factors including availability and 
timing of tests and the ease with which patients could be reviewed also influenced participants’ 
decision making.  
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Figure 1 Histogram with density plot demonstrating the voting frequencies from each 
round  
 
